Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration

The STK11 gene mutation is a common genetic alteration in non-small cell lung cancer (NSCLC) and is significantly associated with poor responses to current immunotherapy regimens. Despite its prevalence, there is currently no established standard for front-line treatment in this subtype of NSCLC, un...

全面介紹

書目詳細資料

Principais autores:	Du Feng, Huixin Jiang, Gengjia Chen, Wenhui Guan, Lin Yi, Yue Zhu, Yijia Li, Gengda Huang, Bin He, Junlong Tang, Yujie Tang, Jiyuan Zeng, Wensheng Zhou, Jiayu Shi, Zhanhong Xie, Ming Liu, Xiaohong Xie, Xinqing Lin, Chengzhi Zhou
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2024-12-01
叢編:	Frontiers in Immunology
主題:	STK11 mutation lung adenocarcinoma case report cadonilimab front-line therapy
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1485358/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!